There is continued debate whether coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) should be the preferred treatment for nondiabetic patients with multivessel coronary artery disease (CAD) and stable ischemic heart disease (SIHD). A paper published Nov. 16 in JACC: Cardiovascular Interventions looks at both sides of the debate. Read more on ACC.org.